On the occurrence of lipoprotein-x in non-hemolytic jaundice.
In cholestasis, serum lipids are altered. The alterations could at least partially be ascribed to the occurrence of an abnormal lipoprotein, LP-X. In 103 patients with jaundice, out of whom 16 had extra-hepatic cholestasis, the presence of LP-X was tested and semi-quantificated (by visual grading) utilizing an immunological technique. In extra-hepatic cholestasis, all patients showed LP-X in serum, while in intra-hepatic drug-induced cholestasis 87% revealed this phenomenon. At the initial stage of acute hepatitis, in drug-induced cholestasis, and in extra-hepatic cholestasis, the semi-quantificated LP-X correlated with alkaline phosphatase values. In extra-hepatic cholestasis, LP-X disappeared soon after the obstruction was relieved by operation.
D001663:Bilirubin / Q000097:blood; D002769:Cholelithiasis / Q000097:blood / Q000601:surgery; D002779:Cholestasis / Q000097:blood / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005878:Gilbert Disease / Q000097:blood; D006506:Hepatitis A / Q000097:blood; D006801:Humans; D007565:Jaundice / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood*; D008105:Liver Cirrhosis, Biliary / Q000097:blood; D008111:Liver Function Tests; D010190:Pancreatic Neoplasms / Q000097:blood / Q000601:surgery; D011247:Pregnancy
D008077:Lipoproteins, LDL; D001663:Bilirubin